3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
7
Phase 3
3
Phase 1/2
3
Phase NA
1
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
10
Urinary Bladder Neoplasms
2
Carcinoma, Hepatocellular
2
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Recurrence
1
Non-Muscle Invasive Bladder Neoplasms
1
Lymphoma, Large B-Cell, Diffuse
1
Leiomyosarcoma
1
Esophageal Neoplasms
1
Disease Progression
1
Breast Diseases
1
Amenorrhea
1
Interventions
Esophagectomy
9
Radiotherapy
8
Endoscopic Mucosal Resection
7
Standard of Care
6
Exercise
6
Enteral Nutrition
6
Endoscopy
6
Magnetic Resonance Spectroscopy
5
Fluorouracil
5
Cisplatin
5
Surveys and Questionnaires
4
camrelizumab
3
Yoga
3
Radiofrequency Ablation
3
Radiation
3
Preoperative Exercise
3
Practice Guidelines as Topic
3
Fluorodeoxyglucose F18
3
Chemoradiotherapy
3
Blood Specimen Collection
3
Biopsy
3
spartalizumab
2
X-Rays
2
Robotic Surgical Procedures
2
Psychosocial Intervention
2
Psychiatric Rehabilitation
2
Proton Therapy
2
Physical Therapy Modalities
2
Palliative Care
2
Paclitaxel
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Esophageal Neoplasms
×
Epirubicin
×
Clear all
NCT02358863
2018-09-06
mEGA
Georgetown University
Phase NA
Terminated
13 enrolled
6 charts